Blog
- Bispecific Antibody Drug Conjugates (ADCs): Emerging Trends
- Nectin-4: New Antibody-Drug Conjugate (ADC) Target
- Aptamer-Drug Conjugate (ApDC): Current Research Progress
- ADC Drugs Targeting Claudin18.2
- Maytansinoids as Payloads of ADCs: DM1, DM4
- Emerging Antibody–siRNA Conjugates (ARC)
- Antibody-drug Conjugates for HER2-Positive Gastric Cancer
- c-MET: A Novel Target for Anticancer Therapies
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)
- Nectin-4-Directed Drugs for Solid Tumors